Circio Holding ASA
Developing circular RNA medicines for gene and cell therapies for hard-to-treat diseases.
CRNA | OL
Overview
Corporate Details
- ISIN(s):
- NO0012858564 (+5 more)
- LEI:
- 5967007LIEEXZXFYNS31
- Country:
- Norway
- Address:
- Vollsveien 19, 1366 Lysaker
- Website:
- https://www.targovax.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Circio Holding ASA is a clinical-stage biotechnology company developing novel medicines based on its unique circular RNA (circRNA) expression platform. The company's primary focus is deploying its powerful circRNA vector technology to enhance next-generation gene and cell therapies for genetic and other difficult-to-treat diseases. Circio's proprietary platform is engineered for novel DNA, RNA, and viral therapeutics. The company also develops immunotherapies, including the TG01 cancer vaccine, with the strategic goal of becoming a leader in the field of circular RNA-based medicine.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Circio Holding ASA and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-09 09:53 |
Share Issue/Capital Change
Circio Holding ASA: Registration of share capital increase following conversion…
|
English | 2.5 KB | |
| 2025-09-05 10:29 |
Capital/Financing Update
Circio Holding ASA - Conversion of Convertible Bonds and funding requested unde…
|
English | 4.0 KB | |
| 2025-08-28 07:00 |
Investor Presentation
Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in …
|
English | 2.9 MB | |
| 2025-08-28 07:00 |
Interim Report
Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in …
|
English | 836.4 KB | |
| 2025-08-28 07:00 |
Report Publication Announcement
Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in …
|
English | 7.3 KB | |
| 2025-08-21 07:00 |
Report Publication Announcement
Circio invites to first half 2025 report and R&D update webcast on 28 August
|
English | 3.9 KB | |
| 2025-08-04 10:57 |
Capital/Financing Update
Circio Holding ASA Funding requested under additional financing commitment fr…
|
English | 2.6 KB | |
| 2025-07-04 09:22 |
Share Issue/Capital Change
Circio Holding ASA: Registration of share capital increase following conversion…
|
Norwegian | 2.5 KB | |
| 2025-06-30 21:49 |
Share Issue/Capital Change
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | 2.8 KB | |
| 2025-06-30 07:00 |
Regulatory News Service
NeoRegen Biotech and Circio advance circular RNA delivery collaboration into in…
|
English | 6.1 KB | |
| 2025-06-20 11:01 |
Share Issue/Capital Change
Circio Holding ASA: Registration of share capital increase following conversion…
|
Norwegian | 2.6 KB | |
| 2025-06-18 16:57 |
Major Shareholding Notification
Flaggemelding Star Kapital AS - Circio Holding ASA
|
Norwegian | 853 bytes | |
| 2025-06-17 17:17 |
Capital/Financing Update
Circio Holding ASA - Funding requested under financing commitment from Atlas
|
English | 2.8 KB | |
| 2025-06-17 13:48 |
Capital/Financing Update
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | 3.5 KB | |
| 2025-06-16 07:00 |
Environmental & Social Information
TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myelom…
|
English | 593.2 KB |
Automate Your Workflow. Get a real-time feed of all Circio Holding ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Circio Holding ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
